Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNPAT | O15228 | 1/20 | 0.56 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.53 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.52 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | BACE1 | P56817 | 1/20 | 0.49 |
| ▸ | ECE1 | P42892 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30507602 | 1.00 | GNPAT (0.56) | GNPATNAALAD2MMP2ERAP2LNPEP | |
| SCHEMBL29630562 | 0.99 | MMP2 (0.55) | GNPATNAALAD2MMP2ERAP2LNPEP | |
| SCHEMBL30099515 | 0.96 | MMP2 (0.57) | GNPATNAALAD2MMP2ERAP2LNPEP | |
| SCHEMBL29531462 | 0.95 | MMP2 (0.56) | GNPATNAALAD2MMP2ERAP2LNPEP | |
| SCHEMBL29662234 | 0.94 | BACE1 (0.53) | GNPATNAALAD2MMP2FOLH1BACE1 | |
| SCHEMBL30547342 | 0.94 | BACE1 (0.53) | GNPATNAALAD2MMP2FOLH1BACE1 | |
| SCHEMBL30099583 | 0.93 | GNPAT (0.56) | GNPATNAALAD2MMP2ERAP2LNPEP | |
| SCHEMBL30099615 | 0.93 | GNPAT (0.56) | GNPATNAALAD2MMP2ERAP2LNPEP | |
| SCHEMBL29774691 | 0.93 | GNPAT (0.56) | GNPATNAALAD2MMP2ERAP2LNPEP | |
| SCHEMBL30099620 | 0.93 | GNPAT (0.56) | GNPATNAALAD2MMP2ERAP2LNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4709425-A1 | LINKER COMPOUNDS AND LIGAND-DRUG CONJUGATES, PREPARATION METHODS AND USES THEREOF | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (CN) | 2026-03-18 | — | — | EP | claimed |
| WO-2024235105-A1 | LINKER COMPOUNDS AND LIGAND-DRUG CONJUGATES, PREPARATION METHODS AND USES THEREOF | BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. (CN) | 2024-11-21 | — | — | WO | claimed |
| EP-4709425-A1 | LINKER COMPOUNDS AND LIGAND-DRUG CONJUGATES, PREPARATION METHODS AND USES THEREOF | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (CN) | 2026-03-18 | — | — | EP | disclosed |
| WO-2024235105-A1 | LINKER COMPOUNDS AND LIGAND-DRUG CONJUGATES, PREPARATION METHODS AND USES THEREOF | BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. (CN) | 2024-11-21 | — | — | WO | disclosed |